Prof. Dr. Sabine Andergassen

Professur für Theoretische Physik

The research activities of our group focus on the emergent physical behavior of strongly correlated electron systems. Prominent examples of fascina- ting phenomena arising from electronic correlations are high-temperature superconductivity or quantum criticality. The impressive technological advance- ments in the device fabrication strongly stimulated the exploration of new phases of matter. At the same time, the development of new many-body techniques for their theoretical description became a central aspect of the forefront research. In recent years, various renormalization-group approaches lead to significant progress in the understanding of correlated electron systems in and out of equilibrium. In particular, by means of these approaches and of their most recent developments, we investigate the fundamental mechanisms underlying the physical behavior of model systems for materials, cold atomic gases and nanostructures.

Prof. Dr. Sarah Dessì Schmid

Professur für Romanische Philologie

My research interests lie in different aspects of synchronic and diachronic linguistics of French, Italian, Spanish and Catalan: verbal morphology, semantics and syntax (in particular aspect and Aktionsart, mode, tense and aspect interfaces, ‘modal uses’ of imperfect, verbal periphrases); philosophy of language, language theory and semiotics; internal and external language history; variational linguistics (especially theories of standardization). My next projects will focus on participles in verbal periphrases of Romance languages as well as on the relevance and the effectiveness of purist strategies and methods in the process of the consolidation of Romance languages.

Prof. Dr. Kurt Franz

Professur für Islamwissenschaft

coming soon

Prof. Dr. Carolin Huhn

Professur für Effektbasierte Umweltanalytik



Prof. Dr. Julia Skokova

Professur für Translationale Onkologie

Unsere Arbeitsgruppe beschäftigt sich mit der Aufklärung der Mechanismen maligner Entartung der Stammzelle, insbesondere auf dem Gebiet der Leukämieforschung und des prä-leukämischen Knochenmarkversagens. Unsere Arbeitsgruppe beinhaltet auch das Referenzlabor für Gen-Diagnostik und Biobanking des Europäischen Registers für Chronische Neutropenien.

Wir arbeiten mit modernen Techniken, wie z. B. Herstellung und Differenzierung von humanen iPS-Zellen, CRISPR/Cas9-basierter Genmodifikation, Next-Generation Sequenzierung inkl. Whole Genome und Exome Sequenzierung, Deep-Sequenzierung, RNA- und ChIP-Sequenzierung. Wir kombinieren diese Techniken mit in vitro Arbeiten mit primären Zellen von Patienten mit AML, CML und prä-leukämischen Knochenmarkversagens-Erkrankungen, sowie mit in vivo Experimenten in Maus und Zebrafish.

Prof. Dr. Ghazaleh Tabatabai

Professur für Neuroonkologie

The field of Neuro-Oncology is dedicated to patients with tumors in the central and peripheral nervous system. Our work requires an interdisciplinary network of experts. Unfortunately, most neurooncological tumors are incurable. Thus, our laboratory research focuses on gaining more insight into the biology of these tumors as a prerequisite of finding new therapeutic approaches that can then be translated into clinical application.

Prof. Dr. Ulrike von Luxburg

Professur für Theoretische Informatik

Ulrike von Luxburg forscht in der Theorie des maschinellen Lernens. Ihr Schwerpunkt ist im Bereich des unüberwachten Lernens, insbesondere der statistischen Analyse von Algorithmen auf zufälligen Netzwerken und der Entwicklung von Algorithmen für vergleichsbasierten Daten.

Prof. Dr. Heike Brötz-Oesterhelt

Professur für Mikrobielle Wirkstoffe

Bacterial resistance to antibiotics spreads at an alarming rate worldwide. New antibiotics devoid of cross-resistance to established antibiotic classes are urgently needed to maintain our standard of treating bacterial infections and to further enable medical interventions dependend on antibiotic co-medication (e.g. complex surgery, transplantation, aggressive chemotherapy).
Two-thirds of all antibiotic classes in therapeutic application today originate from natural products produced by microorganisms. Researchers of the Brötz-Oesterhelt group search among natural and synthetic compounds from diverse sources for new antibacterial agents still active against multi-resistant bacterial isolates. A special focus is on the elucidation of the molecular mechanisms of action of these new agents by an array of microbiological, biochemical and genetic techniques. Such resistance-breaking compounds usually interfere with new bacterial “targets” or new binding sites at validated targets, thereby demonstrating novel bacterial Achilles heels for antibiotic intervention. Promising agents are further evaluated for their potential to serve as lead structures for antibiotic drug discovery and with respect to their resistance mechanisms.

Prof. Dr. Christian la Fougère

Professor of Nuclear Medicine

Molecular imaging techniques using radiolabeled pharmaceuticals and positron-emission-tomography (PET) for the assessment of pathobiochemical and pathophysiological changes in oncology, neurooncology and neurology. We aim to use those multi-parametric imaging techniques in order to provide an insight in physiological (adaptive) as well as pathophysiological changes in the brain, which may lead to an individualized treatment stratification.

Prof. Dr. Barbara Jäger

Professur für Theoretische Physik

The Theoretical High Energy Physics group investi­gates the phenomenology of elementary particles via precision calculations for collider experiments at high energies, such as the
CERN Large Hadron Collider (LHC). Our aim is an improved understanding of the strong and electroweak interactions that govern the dynamics of elementary particles.

A particular focus of our research is on the physics of the recently discovered Higgs boson. By means of advanced numerical simulations we provide predictions that help to pin down the nature of this particle. Moreover, we try to identify possible signatures of new physics that cannot be accounted for within the Standard Model of elementary particles.

Prof. Dr. Monika Schrimpf

Professur für Japanologie

Meine Forschungsgebiete liegen auf dem Gebiet der japanischen Religionsgeschichte, insbesondere in Moderne und Gegenwart. Aktuell forsche ich zu den Themenfeldern Gender und Religion sowie Medizin und Religion in Japan. Konkret untersuche ich die Bedeutung von Genderkonzeptionen für das religiöse Selbstverständnis zeitgenössischer ordinierter buddhistischer Frauen. Daneben beschäftige ich mich mit Formen der Verflechtung von Medizin und Religion in religiösen Kontexten, frage nach Legitimierungsstrategien und individuellen Standortbestimmungen religiöser AkteurInnen, die therapeutische Praktiken anbieten. Im Mittelpunkt stehen dabei Buddhismus und japanische Neureligionen. Seit dem Jahr 2014 bin ich als Professorin für Japanologie am Asien-Orient-Institut der Universität Tübingen tätig.

Prof. Dr. Jennifer Svaldi

Professur für Klinische Psychologie und Psychotherapie

My research themes focus on mechanisms that cause and maintain pathological eating behavior and body image disturbances in at-risk populations, overweight individuals and individuals with eating disorders. To this end, a variety of designs and methods are used, ranging from fundamental studies (eye tracking, EEG, reaction-time tasks) to laboratory-based behavioral studies, ecological momentary assessment (EMA) studies and applied clinical studies (treatment processes and treatment effects).

Prof. Dr. Marja Timmermans

Professur für Entwicklungsgenetik der Pflanzen

The research in our group follows two major directions. In one, we are studying the role of small non-coding RNAs as mobile instructive signals in development. In the other, we are dissecting mechanisms underlying shoot stem cell homeostasis and organogenesis. In our research we use maize, Arabidopsis thaliana, and the moss Physcomitrella patens as model organisms, as each offers unique experimental advantages and because comparative studies can provide an evolutionary perspective on key genetic pathways.